INCY 5 (Jakafi 5 mg)
Generic Name: ruxolitinib
Pill imprint INCY 5 has been identified as Jakafi 5 mg.
Jakafi is used in the treatment of myelofibrosis; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for INCY 5 (Jakafi 5 mg)
- Generic Name:
- 5 mg
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Incyte Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
More about Jakafi (ruxolitinib)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...